Insight Series: Non-Dilutive Funding
Non-dilutive funding can be a powerful way for startups to fuel growth without giving up equity. This panel brings together founders with experience securing grants and other non-dilutive capital, offering practical insights on identifying opportunities, timing fundraising, and maximizing application success.
Strategize fundraising timing: Learn when to pursue non-dilutive funding versus dilutive sources to optimize your startup’s growth trajectory.
Discover funding opportunities: Explore approaches to identify non-dilutive funding sources beyond traditional SBIR/STTR grants.
Maximize application success: Gain strategies for crafting strong applications and know when to engage external experts to improve your chances.
Speaker Highlight
Speaker Name: Max Sims
Expertise: The CEO and Co-Founder of MindTrace and a University of Rochester MBA who has successfully raised over $4.5M in combined funding, including non-dilutive NSF and NIMH SBIR Phase II awards, to commercialize FDA-registered neurosurgery software.
LinkedIn: https://www.linkedin.com/in/max-h-sims/
2. Speaker Name: Kirk Macolini
Expertise: An SBIR and STTR expert who has secured over $525,000,000 in non-dilutive funding to help advanced technology start-ups commercialize their innovations.
LinkedIn: https://www.linkedin.com/in/kirk-macolini-25148b12/
3. Speaker Name: Jay Reddy
Expertise: As a PhD-trained founder and CEO of Advanced Optronics, Jay Reddy is a Carnegie Mellon Innovation Commercialization Fellow who has successfully secured $650,000+ in non-dilutive NSF funding to bridge the gap between academic research and medical device commercialization.
LinkedIn: https://www.linkedin.com/in/jaywreddy/